LB PHARMACEUTICALS INC

LBRX · CIK 0001691082 · operating

$23.78-0.96%Last updated Mar 3, 12:52 AM

OverviewFinancial Statements Valuation Models

Key Statistics

Valuation

Market Cap$601.61M

P/E—

Fwd P/E-6.42

PEG—

P/S—

P/B1.94

EV/EBITDA-13.37

EV/Rev—

Profitability

Gross Margin—

Op. Margin—

Net Margin—

ROE—

ROA—

FCF Margin—

Financial Health

Current Ratio—

Debt/Equity—

Free Cash Flow—

Div. Yield—

Growth & Other

Revenue Growth—

EPS Growth—

Beta—

52W High$25.6

52W Low$13.36

About LB PHARMACEUTICALS INC

LB PHARMACEUTICALS INC (LBRX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $602 million, LB PHARMACEUTICALS INC is a small-cap company. The stock currently trades at $23.78, down 0.96% today, with a 52-week range of $13.36–$25.60.

Latest News

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance · Feb 10, 2026
LB Pharmaceuticals Announces $100.0 Million Private PlacementYahoo Finance · Feb 5, 2026
LB Pharmaceuticals initiates Phase 2 trial of LB-102Yahoo Finance · Jan 27, 2026
LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development ProgramYahoo Finance · Jan 26, 2026
LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General CounselYahoo Finance · Jan 21, 2026
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & CultureYahoo Finance · Jan 6, 2026
LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® IndicesYahoo Finance · Dec 9, 2025
LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare ConferenceYahoo Finance · Nov 24, 2025
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial OfficerYahoo Finance · Nov 12, 2025
LB Pharmaceuticals Announces Presentation at the Stifel 2025 Healthcare ConferenceYahoo Finance · Nov 6, 2025

Annual Reports (10-K) · 0 filings

No 10-K filings found.